Loopbaan van Feng Tian
Eerdere bekende functies van Feng Tian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Directeur/Bestuurslid | 01-07-2018 | 01-11-2020 |
| Algemeen Directeur | 01-07-2018 | 15-08-2022 | |
| Voorzitter | 01-11-2020 | 15-08-2022 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2015 | 01-07-2018 | |
| President | 01-07-2018 | 15-08-2022 | |
| LuxVitae Therapeutics, Inc. | Oprichter | - | - |
| AMBRX INC | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
| Hoofd Techniek/Wetenschap/O&O | 17-06-2015 | - | |
| President | - | - |
Opleiding van Feng Tian
| University of Florida | Doctorate Degree |
| Peking University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Kaaimaneilanden | 2 |
| China | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| LuxVitae Therapeutics, Inc. |
